Fighting Antibiotic Resistance: Insights Into Human Barriers and New Opportunities DOI Creative Commons

Aubin Pitiot,

Camille Rolin, Carole Seguin‐Devaux

и другие.

BioEssays, Год журнала: 2025, Номер unknown

Опубликована: Март 27, 2025

The public health issue of bacterial multi-resistance to antibiotics has gained awareness among the public, researchers, and pharmaceutical sector. Nevertheless, spread antimicrobial resistance been considerably aggravated by human activities, climate change, subsequent increased release antibiotics, drug-resistant bacteria, antibiotic genes in environment. extensive use for medical veterinary purposes not only induced increasing but also other problems, including negative effects on patient's microbiome. Preventive strategies, new treatment modalities, surveillance are progressively set up. A comprehensive approach is, however, lacking urgently tackling this adverse situation. To address challenge, we discussed here main causes driving pollution environment factors favorable emergence drug resistance. We next propose some key priorities research, prevention, surveillance, education supervise an effective clinical sustainable response.

Язык: Английский

Advancements in Antibacterial Therapy: Feature Papers DOI Creative Commons
Giancarlo Angeles Flores,

Gaia Cusumano,

Roberto Venanzoni

и другие.

Microorganisms, Год журнала: 2025, Номер 13(3), С. 557 - 557

Опубликована: Март 1, 2025

Antimicrobial resistance (AMR) is a growing global health crisis that threatens the efficacy of antibiotics and modern medical interventions. The emergence multidrug-resistant (MDR) pathogens, exacerbated by misuse in healthcare agriculture, underscores urgent need for innovative solutions. (1) Background: AMR arises from complex interactions between human, animal, environmental health, further aggravated overuse inadequate regulation antibiotics. Conventional treatments are increasingly ineffective, necessitating alternative strategies. Emerging approaches, including bacteriophage therapy, antimicrobial peptides (AMPs), nanotechnology, microbial extracellular vesicles (EVs), CRISPR-based antimicrobials, provide novel mechanisms complement traditional combating resistant pathogens. (2) Methods: This review critically analyzes advanced antibacterial strategies conjunction with systemic reforms such as stewardship programs, One Health framework, surveillance tools. These methods can enhance detection, guide interventions, promote sustainable practices. Additionally, economic, logistical, regulatory challenges impeding their implementation evaluated. (3) Results: technologies, CRISPR exhibit promising potential targeting mechanisms. However, disparities resource distribution barriers hinder widespread adoption. Public–private partnerships agriculture practices critical to overcoming these obstacles. (4) Conclusions: A holistic integrated approach essential mitigating impact AMR. By aligning therapeutic policies, fostering interdisciplinary collaboration, ensuring equitable distribution, we develop response this 21st-century challenge.

Язык: Английский

Процитировано

1

Coumarin derivatives containing the 1,3,4 oxadiazole/thiadiazole moiety discovered as potential anti-tobacco mosaic virus agents DOI Creative Commons

Yuzhi Hu,

Zhiling Sun, Wei Zeng

и другие.

Molecular Diversity, Год журнала: 2025, Номер unknown

Опубликована: Янв. 20, 2025

Язык: Английский

Процитировано

0

Molecular dynamics simulation-driven focused virtual screening and experimental validation of Fisetin as an inhibitor of Helicobacter pylori HtrA protease DOI

Li Gao,

Xianqiong Jiang,

Hongtao Duan

и другие.

Molecular Diversity, Год журнала: 2025, Номер unknown

Опубликована: Фев. 23, 2025

Язык: Английский

Процитировано

0

Fighting Antibiotic Resistance: Insights Into Human Barriers and New Opportunities DOI Creative Commons

Aubin Pitiot,

Camille Rolin, Carole Seguin‐Devaux

и другие.

BioEssays, Год журнала: 2025, Номер unknown

Опубликована: Март 27, 2025

The public health issue of bacterial multi-resistance to antibiotics has gained awareness among the public, researchers, and pharmaceutical sector. Nevertheless, spread antimicrobial resistance been considerably aggravated by human activities, climate change, subsequent increased release antibiotics, drug-resistant bacteria, antibiotic genes in environment. extensive use for medical veterinary purposes not only induced increasing but also other problems, including negative effects on patient's microbiome. Preventive strategies, new treatment modalities, surveillance are progressively set up. A comprehensive approach is, however, lacking urgently tackling this adverse situation. To address challenge, we discussed here main causes driving pollution environment factors favorable emergence drug resistance. We next propose some key priorities research, prevention, surveillance, education supervise an effective clinical sustainable response.

Язык: Английский

Процитировано

0